Basic Information

Terpenoid ID TKC118419
Chirality TKC206901
Cell line 0
Protein target 66
DiseaseNCIT 0
ORDO 0
ICD 211

Active subnetwork


Terpenoid-cell-disease Activity Association

ID Cell Line Synonyms Value Unit Type NCIt ORDO
TKC118419 HEK293 2908.0 nM Potency
TKC118419 SH-SY5Y SH-Sy5y; SHSY5Y; SHSY-5Y; SK-SH-SY5Y; SY5Y; SH-SY5Y Parental 35481.0 nM Potency C3270 Orphanet_635
TKC118419 M14 M14-MEL; UCLA-SO-M14; UCLA SO M14; UCLA-SO-14; UCLASO-M14; Melanoma 14; M-14 2153.0 nM GI50 C3802
TKC118419 RPMI-8226 RPMI 8226; RPMI.8226; RPMI8226; RPMI no. 8226; RPMI no 8226; RPMI #8226; 8226; RPMI 8226/S; RPMI-8226S; RPMI8226/S; 8226/S; Roswell Park Memorial Institute 8226; GM02132; GM2132; GM 2132; GM02132C; Simpson 2427.0 nM GI50 C3242 Orphanet_29073
TKC118419 LOX IMVI LOX/IMVI; LOX IMVI; LOXIM-VI; LOXIMVI; LOX 3664.0 nM GI50 C3802
TKC118419 SK-MEL-2 SK-Mel-2; SK-Mel 2; SK-mel-2; SK-MEL2; SK.MEL.2; SK Mel 2; SK MEL 2; SKMEL-2; SKMEL2; SKmel2; SK-ML2; SKml2 2208.0 nM GI50 C3224
TKC118419 CCRF-CEM CCRF/CEM; CCRFCEM; CCRF.CEM; CCRF CEM; CCRF; CEM; CEM-CCRF; CEM-CCRF (CAMR); CCRF/CEM/0; CEM/0; CEM-0; CCRF-CEM/S; GM03671; GM03671C 1.0 ug ml-1 CT50 C7953 Orphanet_99861
TKC118419 HEK293 7830.0 nM CC50
TKC118419 SN12C SN-12C 7145.0 nM GI50 C9385 Orphanet_217071
TKC118419 MDA-N MDAN 15066.0 nM GI50 C3802
TKC118419 NCI-H23 NCI.H23; NCI H23; H-23; H23; NCIH23 35727.0 nM GI50 C3512
TKC118419 UO-31 UO.31; UO31; U031 665.0 nM GI50 C9385 Orphanet_217071
TKC118419 ACHN 13552.0 nM GI50 C6975 Orphanet_319298
TKC118419 DU-145 DU-145; Du-145; DU 145; DU_145; DU.145; Duke University 145 3342.0 nM GI50 C4863
TKC118419 SF-539 SF-539; SF-539 BT; SF.539; SF 539 2825.0 nM GI50 C3796 Orphanet_251576
TKC118419 SK-MEL-5 SK-Mel-5; SK MEL 5; SK.MEL.5; SK-MEL5; SKMel-5; SKMEL-5; SKMEL5; SKMel5; SKmel5; AA-Mel 11455.0 nM GI50 C3510
TKC118419 K562 K562; K.562; K 562; KO; GM05372; GM05372E 37154.0 nM GI50 C9110 Orphanet_521
TKC118419 OVCAR-3 Ovcar-3; OVCAR 3; OVCAR.3; NIH:OVCAR-3; NIH:Ovcar-3; NIH:OVCAR3; NIH-OVCAR-3; NIHOVCAR3; OVCAR3; Ovcar3 4645.0 nM GI50 C105555
TKC118419 MOLT-4 Molt-4; MOLT 4; Molt 4; MOLT.4; MOLT4; Molt4; GM02219; GM02219C; GM2219C; GM02219D 2089.0 nM GI50 C9142 Orphanet_99861
TKC118419 HOP-62 HOP 62; Hop 62; HOP.62; HOP62; Hop62; Hopkins-62 3048.0 nM GI50 C3512
TKC118419 NCI/ADR-RES NCI/ADR-RES; NCI.ADR.RES; NCIADR.RES; NCI/ADRRES; NCIADRRES; ADR-RES; MCF-7/ADR; MCF-7/ADR-RES; MCF-7/AdrR; MCF-7/Adr; MCF-7/adr; MCF-7ADR; MCF7-ADR; MCF7ADR; OVCAR-8/ADR; OVCAR8/ADR 38815.0 nM GI50 C105555
TKC118419 OVCAR-5 OVCAR 5; NIH:OVCAR-5; OVCAR.5; OVCAR5; Ovcar5; OVCA5 14997.0 nM GI50 C105555
TKC118419 OVCAR-8 OVCAR 8; NIH:OVCAR-8; OVCAR8; Ovcar8; OVCAR.8; OVCA8 25003.0 nM GI50 C105555
TKC118419 SNB-19 SNB.19; SNB19; Surgical Neurology Branch-19 6383.0 nM GI50 C60781 Orphanet_94
TKC118419 SR SR-786; SR786 1837.0 nM GI50 C37193 Orphanet_300895
TKC118419 TK-10 TK.10; TK 10; TK10 11858.0 nM GI50 C4033 Orphanet_319276
TKC118419 SW-620 SW-620; SW 620; SW.620 17742.0 nM GI50 C4349
TKC118419 NCI-H522 NCI.H522; H522; H-522; NCI-522; NCI522; NCIH522 13836.0 nM GI50 C3512
TKC118419 KM12 KM-12; KM.12 11455.0 nM GI50 C4910
TKC118419 HCC 2998 HCC-2998; HCC.2998; HCC 2998; Hamon Cancer Center 2998 2158.0 nM GI50 C4349
TKC118419 SNB-75 SNB.75; SNB75; Surgical Neurology Branch-75 323.0 nM GI50 C3058 Orphanet_360
TKC118419 HCT-15 HCT-15; HCT.15; HCT15 9908.0 nM GI50 C4349
TKC118419 SF-268 SF-268; SF.268; SF 268 21429.0 nM GI50 C60781 Orphanet_94
TKC118419 HCT-116 HCT-116; HCT.116; HCT_116; HCT116; HCT116wt; CoCL2 13428.0 nM GI50 C4910
TKC118419 MCF7 100000.0 nM IC50 C4194
TKC118419 EKVX 9661.0 nM GI50 C3512
TKC118419 T47D 637.0 nM GI50 C4194
TKC118419 NCI-H460 NCI.H460; H460; H-460; NCIH460; NCI-HUT-460; NCI-460 8954.0 nM GI50 C4450
TKC118419 UACC-62 UACC 62; UACC.62; UACC62; University of Arizona Cell Culture-62 1306.0 nM GI50 C3224
TKC118419 CAKI-1 CAL 1; Centre Antoine Lacassagne-1 11.0 nM GI50 C3224
TKC118419 MDA-MB-435 MDA-MB435; MDAMB435; MDA.MB.435; MDA-435; MDA 435; MDA435; MD Anderson-Metastatic Breast-435 3251.0 nM GI50 C3802
TKC118419 SF-295 SF-295; SF.295; SF 295 2958.0 nM GI50 C3058 Orphanet_360
TKC118419 IGROV-1 Igrov-1; IGROV 1; IGR-OV1; IGROV1; Igrov1; IGR.OV1; IGROV; OV1/P; OV1/p; OV1-P 1276.0 nM GI50 C7979 Orphanet_454723
TKC118419 UACC-257 UACC 257; UACC.257; UACC257; University of Arizona Cell Culture-257 2951.0 nM GI50 C3224
TKC118419 786-0 786-o; 786O; 786-0; 786.O; 786-O RCC; RCC 786-O; RCC_7860; RCC 7860; 7860; 786-0WT 8433.0 nM GI50 C9385 Orphanet_217071
TKC118419 SK-MEL-28 SK-Mel-28; SK.MEL.28; SK-MEL 28; SK MEL-28; SK MEL 28; SK Mel 28; SKMel-28; SKMEL-28; SK-MEL28; SK-Mel28; SK Mel28; SKMEL28; SKMel28; SKmel28; SKML-28; SK28; AU-Mel; P-36; P36 7447.0 nM GI50 C3510
TKC118419 HT-29 HT 29; HT29 1968.0 nM GI50 C4349
TKC118419 COLO 205 Colo 205; CoLo 205; COLO-205; Colo-205; COLO.205; Colo205; COLO205; Co 205; Colorado 205 10000.0 nM GI50 C4349

Terpenoid-protein target Activity Association

ID Uniport Pref_name Gene name value unit type
TKC118419 Q12809 Potassium voltage-gated channel subfamily H member 2 KCNH2 17783 nM Potency
TKC118419 P00352 Retinal dehydrogenase 1 ALDH1A1 28184 nM Potency
TKC118419 P10636 Microtubule-associated protein tau MAPT 14125 nM Potency
TKC118419 P11473 Vitamin D3 receptor VDR 44668 nM Potency
TKC118419 Q16637 Survival motor neuron protein SMN1,SMN2 22387 nM Potency
TKC118419 Q16637 Survival motor neuron protein SMN1,SMN2 22387 nM Potency
TKC118419 Q9NUW8 Tyrosyl-DNA phosphodiesterase 1 TDP1 631 nM Potency
TKC118419 P31749 RAC-alpha serine/threonine-protein kinase AKT1 96 % Inhibition
TKC118419 P07900 Heat shock protein HSP 90-alpha HSP90AA1 363 nM AC50
TKC118419 O75874 Isocitrate dehydrogenase [NADP] cytoplasmic IDH1 19953 nM Potency
TKC118419 P53350 Serine/threonine-protein kinase PLK1 PLK1 6 nM IC50
TKC118419 P53350 Serine/threonine-protein kinase PLK1 PLK1 1500 nM Ki
TKC118419 P53350 Serine/threonine-protein kinase PLK1 PLK1 24 nM IC50
TKC118419 P84022 Mothers against decapentaplegic homolog 3 SMAD3 10000 nM Potency
TKC118419 Q03431 Parathyroid hormone/parathyroid hormone-related peptide receptor PTH1R 56234 nM Potency
TKC118419 Q14191 Werner syndrome ATP-dependent helicase WRN 14125 nM Potency
TKC118419 Q16236 Nuclear factor erythroid 2-related factor 2 NFE2L2 3663 nM Potency
TKC118419 Q77YF9 Protein Vpr vpr 17783 nM Potency
TKC118419 Q99700 Ataxin-2 ATXN2 25119 nM Potency
TKC118419 P27695 DNA-(apurinic or apyrimidinic site) endonuclease APEX1 44668 nM Potency
TKC118419 Q9UBT6 DNA polymerase kappa POLK 39811 nM Potency
TKC118419 Q9UNA4 DNA polymerase iota POLI 56234 nM Potency
TKC118419 O75496 Geminin GMNN 12589 nM Potency
TKC118419 O89049 Thioredoxin reductase 1, cytoplasmic Txnrd1 2818 nM Potency
TKC118419 P37840 Alpha-synuclein SNCA 9200 nM Potency
TKC118419 Q9HC16 DNA dC->dU-editing enzyme APOBEC-3G APOBEC3G 17783 nM Potency
TKC118419 O94782 Ubiquitin carboxyl-terminal hydrolase 1 USP1 39811 nM Potency
TKC118419 P39748 Flap endonuclease 1 FEN1 13371 nM Potency
TKC118419 Q13148 TAR DNA-binding protein 43 TARDBP 1000 nM Potency
TKC118419 Q13526 Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 PIN1 67456 nM Potency
TKC118419 O42275 Acetylcholinesterase ache 16 % Inhibition
TKC118419 P06239 Tyrosine-protein kinase Lck LCK 95 % Inhibition
TKC118419 P0DTD1 Replicase polyprotein 1ab rep 5 % Inhibition
TKC118419 P17252 Protein kinase C alpha type PRKCA 68 % Activity
TKC118419 P27361 Mitogen-activated protein kinase 3 MAPK3 106 % Activity
TKC118419 P28482 Mitogen-activated protein kinase 1 MAPK1 90 % Activity
TKC118419 P81908 Cholinesterase BCHE -6 % Inhibition
TKC118419 Q16539 Mitogen-activated protein kinase 14 MAPK14 86 % Inhibition
TKC118419 Q96KQ7 Histone-lysine N-methyltransferase EHMT2 EHMT2 6310 nM Potency
TKC118419 P63096 Guanine nucleotide-binding protein G GNAI1 11220 nM Potency
TKC118419 Q01453 Peripheral myelin protein 22 PMP22 37933 nM Potency
TKC118419 Q6W5P4 Neuropeptide S receptor NPSR1 10000 nM Potency
TKC118419 O00255 Menin MEN1 22387 nM Potency
TKC118419 P15428 15-hydroxyprostaglandin dehydrogenase [NAD(+)] HPGD 35481 nM Potency
TKC118419 P46063 ATP-dependent DNA helicase Q1 RECQL 22387 nM Potency
TKC118419 Q9F4F7 4'-phosphopantetheinyl transferase ffp ffp 50119 nM Potency
TKC118419 P10828 Thyroid hormone receptor beta THRB 31623 nM Potency
TKC118419 P49798 Regulator of G-protein signaling 4 RGS4 4228 nM Potency
TKC118419 Q03164 Histone-lysine N-methyltransferase 2A KMT2A 39811 nM Potency
TKC118419 Q9NR56 Muscleblind-like protein 1 MBNL1 15849 nM Potency
TKC118419 P51450 Nuclear receptor ROR-gamma Rorc 11220 nM Potency
TKC118419 O94925 Glutaminase kidney isoform, mitochondrial GLS 3548 nM Potency
TKC118419 P02545 Prelamin-A/C LMNA 11220 nM Potency
TKC118419 O15530 3-phosphoinositide-dependent protein kinase 1 PDPK1 91 % Activity
TKC118419 P11309 Serine/threonine-protein kinase pim-1 PIM1 87 % Activity
TKC118419 P49841 Glycogen synthase kinase-3 beta GSK3B 65 % Activity
TKC118419 P51955 Serine/threonine-protein kinase Nek2 NEK2 81 % Activity
TKC118419 Q02750 Dual specificity mitogen-activated protein kinase kinase 1 MAP2K1 63 % Activity
TKC118419 Q96GD4 Aurora kinase B AURKB 83 % Activity
TKC118419 Q9HC98 Serine/threonine-protein kinase Nek6 NEK6 113 % Activity
TKC118419 O15264 Mitogen-activated protein kinase 13 MAPK13 79 % Inhibition
TKC118419 P42345 Serine/threonine-protein kinase mTOR MTOR 40 nM IC50
TKC118419 P42345 Serine/threonine-protein kinase mTOR MTOR 9200 nM Kd
TKC118419 O15438 ATP-binding cassette sub-family C member 3 ABCC3 133000 nM IC50
TKC118419 O15439 ATP-binding cassette sub-family C member 4 ABCC4 63200 nM IC50
TKC118419 O95342 Bile salt export pump ABCB11 13600 nM IC50
TKC118419 O95342 Bile salt export pump ABCB11 13600 nM IC50
TKC118419 Q92887 ATP-binding cassette sub-family C member 2 ABCC2 46100 nM IC50
TKC118419 Q99814 Endothelial PAS domain-containing protein 1 EPAS1 3930 nM IC50
TKC118419 P15289 Arylsulfatase A ARSA 2393 nM Potency
TKC118419 P45983 Mitogen-activated protein kinase 8 MAPK8 84 % Activity
TKC118419 P10253 Lysosomal alpha-glucosidase GAA 31623 nM Potency
TKC118419 P11308 Transcriptional regulator ERG ERG 22387 nM Potency
TKC118419 P62826 GTP-binding nuclear protein Ran RAN 28184 nM Potency
TKC118419 Q9H4B4 Serine/threonine-protein kinase PLK3 PLK3 48 nM IC50
TKC118419 Q9H4B4 Serine/threonine-protein kinase PLK3 PLK3 3000 nM Ki
TKC118419 Q9NYY3 Serine/threonine-protein kinase PLK2 PLK2 2800 nM Ki
TKC118419 P05067 Amyloid-beta precursor protein APP 231 nM Potency
TKC118419 P97697 Inositol monophosphatase 1 Impa1 1995 nM Potency
TKC118419 P42336 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PIK3CA 1 nM IC50
TKC118419 P42336 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PIK3CA 12 nM IC50
TKC118419 P42336 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PIK3CA 17.6 nM IC50
TKC118419 P42336 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PIK3CA 120 nM Ki
TKC118419 P42336 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PIK3CA 12 nM IC50
TKC118419 P42336 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PIK3CA 12 nM IC50
TKC118419 P42336 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PIK3CA 13 nM IC50
TKC118419 P42336 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PIK3CA 1 nM IC50
TKC118419 P42336 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PIK3CA 5.4 nM Kd
TKC118419 P48736 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PIK3CG 5 nM IC50
TKC118419 P48736 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PIK3CG 19 nM IC50
TKC118419 P48736 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PIK3CG 55 nM IC50
TKC118419 P48736 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PIK3CG 55000 nM IC50
TKC118419 P48736 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PIK3CG 89 nM IC50
TKC118419 P48736 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PIK3CG 5 nM IC50
TKC118419 P48736 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PIK3CG 15 nM Kd
TKC118419 P49137 MAP kinase-activated protein kinase 2 MAPKAPK2 102 % Inhibition
TKC118419 P0A6C1 Endonuclease 4 nfo 35481 nM Potency
TKC118419 Q99549 M-phase phosphoprotein 8 MPHOSPH8 10000 nM Potency
TKC118419 Q8IL32 Heat shock protein 90, putative PF3D7_1443900 215 nM AC50
TKC118419 Q13627 Dual specificity tyrosine-phosphorylation-regulated kinase 1A DYRK1A 88 % Activity
TKC118419 O14920 Inhibitor of nuclear factor kappa-B kinase subunit beta IKBKB 96 % Activity
TKC118419 O75582 Ribosomal protein S6 kinase alpha-5 RPS6KA5 85 % Activity
TKC118419 P67870 Casein kinase II subunit beta CSNK2B 96 % Activity
TKC118419 P24941 Cyclin-dependent kinase 2 CDK2 95 % Activity
TKC118419 Q15118 Pyruvate dehydrogenase PDK1 88 % Inhibition
TKC118419 O14757 Serine/threonine-protein kinase Chk1 CHEK1 87 % Activity
TKC118419 Q05513 Protein kinase C zeta type PRKCZ 84 % Activity
TKC118419 O00141 Serine/threonine-protein kinase Sgk1 SGK1 86 % Activity
TKC118419 O00329 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PIK3CD 4 nM IC50
TKC118419 O00329 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PIK3CD 9 nM IC50
TKC118419 O00329 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PIK3CD 9 nM IC50
TKC118419 O00329 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PIK3CD 5.5 nM Kd
TKC118419 O00418 Eukaryotic elongation factor 2 kinase EEF2K 97 % Activity
TKC118419 O43781 Dual specificity tyrosine-phosphorylation-regulated kinase 3 DYRK3 84 % Activity
TKC118419 O75116 Rho-associated protein kinase 2 ROCK2 99 % Activity
TKC118419 O96013 Serine/threonine-protein kinase PAK 4 PAK4 90 % Activity
TKC118419 O96017 Serine/threonine-protein kinase Chk2 CHEK2 90 % Activity
TKC118419 P00523 Proto-oncogene tyrosine-protein kinase Src SRC 83 % Activity
TKC118419 P06240 Proto-oncogene tyrosine-protein kinase LCK Lck 73 % Activity
TKC118419 P0AE70 Endoribonuclease toxin MazF mazF >99000 nM EC50
TKC118419 P0AE70 Endoribonuclease toxin MazF mazF >99000 nM EC50
TKC118419 P0AE70 Endoribonuclease toxin MazF mazF >99000 nM EC50
TKC118419 P11799 Myosin light chain kinase, smooth muscle Mylk 260 nM IC50
TKC118419 P17612 cAMP-dependent protein kinase catalytic subunit alpha PRKACA 86 % Activity
TKC118419 P23443 Ribosomal protein S6 kinase beta-1 RPS6KB1 95 % Activity
TKC118419 P27448 MAP/microtubule affinity-regulating kinase 3 MARK3 85 % Activity
TKC118419 P27986 Phosphatidylinositol 3-kinase regulatory subunit alpha PIK3R1 1 nM IC50
TKC118419 P27986 Phosphatidylinositol 3-kinase regulatory subunit alpha PIK3R1 4.2 nM IC50
TKC118419 P27986 Phosphatidylinositol 3-kinase regulatory subunit alpha PIK3R1 103 nM IC50
TKC118419 P27986 Phosphatidylinositol 3-kinase regulatory subunit alpha PIK3R1 11.9 nM IC50
TKC118419 P27986 Phosphatidylinositol 3-kinase regulatory subunit alpha PIK3R1 1610 nM IC50
TKC118419 P31751 RAC-beta serine/threonine-protein kinase AKT2 90 % Activity
TKC118419 P32871 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PIK3CA 0 % Inhibition
TKC118419 P41240 Tyrosine-protein kinase CSK CSK 73 % Activity
TKC118419 P42338 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PIK3CB 8 nM Kd
TKC118419 P42338 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PIK3CB 7.6 nM Kd
TKC118419 P42338 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PIK3CB 10 nM IC50
TKC118419 P42338 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PIK3CB 15 nM IC50
TKC118419 P42338 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PIK3CB 14 nM IC50
TKC118419 P45984 Mitogen-activated protein kinase 9 MAPK9 83 % Activity
TKC118419 P48730 Casein kinase I isoform delta CSNK1D 94 % Activity
TKC118419 P51812 Ribosomal protein S6 kinase alpha-3 RPS6KA3 90 % Activity
TKC118419 P53778 Mitogen-activated protein kinase 12 MAPK12 75 % Inhibition
TKC118419 P53779 Mitogen-activated protein kinase 10 MAPK10 97 % Activity
TKC118419 P78527 DNA-dependent protein kinase catalytic subunit PRKDC 120 nM Ki
TKC118419 P78527 DNA-dependent protein kinase catalytic subunit PRKDC 120 nM Ki
TKC118419 Q13188 Serine/threonine-protein kinase 3 STK3 96 % Activity
TKC118419 Q14012 Calcium/calmodulin-dependent protein kinase type 1 CAMK1 97 % Activity
TKC118419 Q14680 Maternal embryonic leucine zipper kinase MELK 61 % Activity
TKC118419 Q15139 Serine/threonine-protein kinase D1 PRKD1 92 % Activity
TKC118419 Q15418 Ribosomal protein S6 kinase alpha-1 RPS6KA1 86 % Activity
TKC118419 Q15746 Myosin light chain kinase, smooth muscle MYLK 170 nM IC50
TKC118419 Q15759 Mitogen-activated protein kinase 11 MAPK11 74 % Inhibition
TKC118419 Q16513 Serine/threonine-protein kinase N2 PKN2 71 % Activity
TKC118419 Q16644 MAP kinase-activated protein kinase 3 MAPKAPK3 98 % Activity
TKC118419 Q62868 Rho-associated protein kinase 2 Rock2 91 % Inhibition
TKC118419 Q86V86 Serine/threonine-protein kinase pim-3 PIM3 86 % Activity
TKC118419 Q8IW41 MAP kinase-activated protein kinase 5 MAPKAPK5 69 % Activity
TKC118419 Q8IWQ3 Serine/threonine-protein kinase BRSK2 BRSK2 80 % Activity
TKC118419 Q8N5S9 Calcium/calmodulin-dependent protein kinase kinase 1 CAMKK1 83 % Activity
TKC118419 Q8TD08 Mitogen-activated protein kinase 15 MAPK15 98 % Activity
TKC118419 Q8TDX7 Serine/threonine-protein kinase Nek7 NEK7 100 % Activity
TKC118419 Q92630 Dual specificity tyrosine-phosphorylation-regulated kinase 2 DYRK2 98 % Activity
TKC118419 Q96RR4 Calcium/calmodulin-dependent protein kinase kinase 2 CAMKK2 71 % Activity
TKC118419 Q96SB4 SRSF protein kinase 1 SRPK1 73 % Activity
TKC118419 Q9BUB5 MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1 81 % Activity
TKC118419 Q9H1R3 Myosin light chain kinase 2, skeletal/cardiac muscle MYLK2 4 % Inhibition
TKC118419 Q9H2X6 Homeodomain-interacting protein kinase 2 HIPK2 94 % Activity
TKC118419 Q9H422 Homeodomain-interacting protein kinase 3 HIPK3 75 % Activity
TKC118419 Q9HBH9 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2 97 % Activity
TKC118419 Q9NQU5 Serine/threonine-protein kinase PAK 6 PAK6 86 % Activity
TKC118419 Q9P1W9 Serine/threonine-protein kinase pim-2 PIM2 83 % Activity
TKC118419 Q9P286 Serine/threonine-protein kinase PAK 5 PAK5 72 % Activity
TKC118419 Q9UQB9 Aurora kinase C AURKC 69 % Activity
TKC118419 O00444 Serine/threonine-protein kinase PLK4 PLK4 >20000 nM Ki

Protein target-disease Activity Association

Uniport ID Uniport Name ICD-11
Q12809 KCNH2_HUMAN Heart failure [ICD-11: BD10-BD1Z]
Q12809 KCNH2_HUMAN Sleep-wake disorder [ICD-11: 7A00-7B2Z]
Q12809 KCNH2_HUMAN Malaria [ICD-11: 1F40-1F45]
Q12809 KCNH2_HUMAN Multiple sclerosis [ICD-11: 8A40]
Q12809 KCNH2_HUMAN Pain [ICD-11: MG30-MG3Z]
Q12809 KCNH2_HUMAN Cardiac arrhythmia [ICD-11: BC9Z]
Q12809 KCNH2_HUMAN Angina pectoris [ICD-11: BA40]
Q12809 KCNH2_HUMAN Genetic cardiac arrhythmia [ICD-11: BC65]
Q12809 KCNH2_HUMAN Ovarian cancer [ICD-11: 2C73]
P10636 TAU_HUMAN Acute myeloid leukaemia [ICD-11: 2A60]
P10636 TAU_HUMAN Alzheimer disease [ICD-11: 8A20]
P10636 TAU_HUMAN Mild neurocognitive disorder [ICD-11: 6D71]
P10636 TAU_HUMAN Choreiform disorder [ICD-11: 8A01]
P10636 TAU_HUMAN Parkinsonism [ICD-11: 8A00]
P10636 TAU_HUMAN Central nervous system disease [ICD-11: 8A04-8D87]
P10636 TAU_HUMAN Neurodegenerative disorder [ICD-11: 8A20-8A23]
P11473 VDR_HUMAN Chronic kidney disease [ICD-11: GB61]
P11473 VDR_HUMAN Hair/hair growth developmental defect [ICD-11: LC30]
P11473 VDR_HUMAN Hyper-parathyroidism [ICD-11: 5A51]
P11473 VDR_HUMAN Hypo-parathyroidism [ICD-11: 5A50]
P11473 VDR_HUMAN Mineral deficiency [ICD-11: 5B5K]
P11473 VDR_HUMAN Psoriasis [ICD-11: EA90]
P11473 VDR_HUMAN Vitamin deficiency [ICD-11: 5B55-5B5F]
P11473 VDR_HUMAN Low bone mass disorder [ICD-11: FB83]
P11473 VDR_HUMAN Acute myeloid leukaemia [ICD-11: 2A60]
P11473 VDR_HUMAN Prostate cancer [ICD-11: 2C82]
P11473 VDR_HUMAN Prostate disease [ICD-11: GA91]
P11473 VDR_HUMAN Abnormal micturition [ICD-11: MF50]
P11473 VDR_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
P11473 VDR_HUMAN Postoperative inflammation [ICD-11: 1A00-CA43]
P11473 VDR_HUMAN Acne vulgaris [ICD-11: ED80]
Q16637 SMN_HUMAN Muscular atrophy [ICD-11: 8B61]
Q16637 SMN_HUMAN Muscular atrophy [ICD-11: 8B61]
Q16637 SMN_HUMAN Muscular atrophy [ICD-11: 8B61]
Q16637 SMN_HUMAN Muscular atrophy [ICD-11: 8B61]
P31749 AKT1_HUMAN Brain cancer [ICD-11: 2A00]
P31749 AKT1_HUMAN Breast cancer [ICD-11: 2C60-2C6Y]
P31749 AKT1_HUMAN Central nervous system disease [ICD-11: 8A04-8D87]
P31749 AKT1_HUMAN Colorectal cancer [ICD-11: 2B91]
P31749 AKT1_HUMAN Diffuse large B-cell lymphoma [ICD-11: 2A81]
P31749 AKT1_HUMAN Malignant haematopoietic neoplasm [ICD-11: 2B33]
P31749 AKT1_HUMAN Prostate cancer [ICD-11: 2C82]
P31749 AKT1_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
P31749 AKT1_HUMAN Stomach cancer [ICD-11: 2B72]
P31749 AKT1_HUMAN Acute myeloid leukaemia [ICD-11: 2A60]
P31749 AKT1_HUMAN Cardiovascular disease [ICD-11: BA00-BE2Z]
P31749 AKT1_HUMAN Injury [ICD-11: NA00-ND5Z]
P31749 AKT1_HUMAN Leukaemia [ICD-11: 2A60-2B33]
P31749 AKT1_HUMAN Lymphoma [ICD-11: 2A80-2A86]
P31749 AKT1_HUMAN Multiple myeloma [ICD-11: 2A83]
P31749 AKT1_HUMAN Ovarian cancer [ICD-11: 2C73]
P31749 AKT1_HUMAN Overgrowth syndrome [ICD-11: LD2C]
P31749 AKT1_HUMAN Pancreatic cancer [ICD-11: 2C10]
P31749 AKT1_HUMAN Parkinsonism [ICD-11: 8A00]
P31749 AKT1_HUMAN Renal cell carcinoma [ICD-11: 2C90]
P31749 AKT1_HUMAN Arterial occlusive disease [ICD-11: BD40]
P07900 HS90A_HUMAN Acute upper respiratory infection [ICD-11: CA07]
P07900 HS90A_HUMAN Asthma [ICD-11: CA23]
P07900 HS90A_HUMAN Vasomotor/allergic rhinitis [ICD-11: CA08]
P07900 HS90A_HUMAN Breast cancer [ICD-11: 2C60-2C6Y]
P07900 HS90A_HUMAN Multiple myeloma [ICD-11: 2A83]
P07900 HS90A_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
P07900 HS90A_HUMAN Lung cancer [ICD-11: 2C25]
P07900 HS90A_HUMAN Malignant haematopoietic neoplasm [ICD-11: 2B33]
P07900 HS90A_HUMAN Mature B-cell leukaemia [ICD-11: 2A82]
P07900 HS90A_HUMAN Stomach cancer [ICD-11: 2B72]
P07900 HS90A_HUMAN Alzheimer disease [ICD-11: 8A20]
P07900 HS90A_HUMAN Encephalopathy [ICD-11: 8E47]
P07900 HS90A_HUMAN Mature B-cell lymphoma [ICD-11: 2A85]
P07900 HS90A_HUMAN Melanoma [ICD-11: 2C30]
P07900 HS90A_HUMAN Neuropathy [ICD-11: 8C0Z]
P07900 HS90A_HUMAN Ovarian cancer [ICD-11: 2C73]
P07900 HS90A_HUMAN Diabetes mellitus [ICD-11: 5A10]
P07900 HS90A_HUMAN Renal cell carcinoma [ICD-11: 2C90]
P07900 HS90A_HUMAN Unspecific body region injury [ICD-11: ND56]
O75874 IDHC_HUMAN Acute myeloid leukaemia [ICD-11: 2A60]
O75874 IDHC_HUMAN Liver cancer [ICD-11: 2C12]
O75874 IDHC_HUMAN Malignant haematopoietic neoplasm [ICD-11: 2B33]
O75874 IDHC_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
O75874 IDHC_HUMAN Acute myeloid leukaemia [ICD-11: 2A60]
O75874 IDHC_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
P53350 PLK1_HUMAN Acute myeloid leukaemia [ICD-11: 2A60]
P53350 PLK1_HUMAN Myelodysplastic syndrome [ICD-11: 2A37]
P53350 PLK1_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
P53350 PLK1_HUMAN Prostate cancer [ICD-11: 2C82]
P53350 PLK1_HUMAN Malignant haematopoietic neoplasm [ICD-11: 2B33]
P53350 PLK1_HUMAN Pancreatic cancer [ICD-11: 2C10]
P53350 PLK1_HUMAN Lymphoma [ICD-11: 2A80-2A86]
P53350 PLK1_HUMAN Nasopharyngeal cancer [ICD-11: 2B6B]
P53350 PLK1_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
P53350 PLK1_HUMAN Acute myeloid leukaemia [ICD-11: 2A60]
P53350 PLK1_HUMAN Myelodysplastic syndrome [ICD-11: 2A37]
P53350 PLK1_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
P53350 PLK1_HUMAN Prostate cancer [ICD-11: 2C82]
P53350 PLK1_HUMAN Malignant haematopoietic neoplasm [ICD-11: 2B33]
P53350 PLK1_HUMAN Pancreatic cancer [ICD-11: 2C10]
P53350 PLK1_HUMAN Lymphoma [ICD-11: 2A80-2A86]
P53350 PLK1_HUMAN Nasopharyngeal cancer [ICD-11: 2B6B]
P53350 PLK1_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
P53350 PLK1_HUMAN Acute myeloid leukaemia [ICD-11: 2A60]
P53350 PLK1_HUMAN Myelodysplastic syndrome [ICD-11: 2A37]
P53350 PLK1_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
P53350 PLK1_HUMAN Prostate cancer [ICD-11: 2C82]
P53350 PLK1_HUMAN Malignant haematopoietic neoplasm [ICD-11: 2B33]
P53350 PLK1_HUMAN Pancreatic cancer [ICD-11: 2C10]
P53350 PLK1_HUMAN Lymphoma [ICD-11: 2A80-2A86]
P53350 PLK1_HUMAN Nasopharyngeal cancer [ICD-11: 2B6B]
P53350 PLK1_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
P84022 SMAD3_HUMAN Herpes simplex infection [ICD-11: 1F00]
P84022 SMAD3_HUMAN Kidney fibrosis [ICD-11: GC01]
Q03431 PTH1R_HUMAN Low bone mass disorder [ICD-11: FB83]
Q03431 PTH1R_HUMAN Hypo-parathyroidism [ICD-11: 5A50]
Q14191 WRN_HUMAN Mature T-cell lymphoma [ICD-11: 2A90]
Q16236 NF2L2_HUMAN Ataxic disorder [ICD-11: 8A03]
Q16236 NF2L2_HUMAN Breast cancer [ICD-11: 2C60-2C6Y]
Q16236 NF2L2_HUMAN Glaucoma [ICD-11: 9C61]
Q16236 NF2L2_HUMAN Lung cancer [ICD-11: 2C25]
Q16236 NF2L2_HUMAN Macular degeneration [ICD-11: 9B75]
Q16236 NF2L2_HUMAN Melanoma [ICD-11: 2C30]
Q16236 NF2L2_HUMAN Mental/behavioural/neurodevelopmental disorder [ICD-11: 6E20-6E8Z]
Q16236 NF2L2_HUMAN Pulmonary hypertension [ICD-11: BB01]
Q16236 NF2L2_HUMAN Subarachnoid haemorrhage [ICD-11: 8B01]
Q16236 NF2L2_HUMAN Urinary system clinical sympton [ICD-11: MF8Y]
Q16236 NF2L2_HUMAN Non-alcoholic fatty liver disease [ICD-11: DB92]
Q16236 NF2L2_HUMAN Alpha-1-antitrypsin deficiency [ICD-11: 5C5A]
Q16236 NF2L2_HUMAN Motor neuron disease [ICD-11: 8B60]
Q16236 NF2L2_HUMAN Multiple sclerosis [ICD-11: 8A40]
P27695 APEX1_HUMAN Retinopathy [ICD-11: 9B71]
P27695 APEX1_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
P27695 APEX1_HUMAN Ocular cancer [ICD-11: 2D00-2D07]
P27695 APEX1_HUMAN Brain cancer [ICD-11: 2A00]
P27695 APEX1_HUMAN Melanoma [ICD-11: 2C30]
P37840 SYUA_HUMAN Parkinsonism [ICD-11: 8A00]
P37840 SYUA_HUMAN Alzheimer disease [ICD-11: 8A20]
P37840 SYUA_HUMAN Autonomic nervous system disorder [ICD-11: 8D87]
O94782 UBP1_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
Q13148 TADBP_HUMAN Acute myeloid leukaemia [ICD-11: 2A60]
Q13148 TADBP_HUMAN Alzheimer disease [ICD-11: 8A20]
Q13526 PIN1_HUMAN Lung cancer [ICD-11: 2C25]
Q13526 PIN1_HUMAN Nasopharyngeal cancer [ICD-11: 2B6B]
P06239 LCK_HUMAN Multiple myeloma [ICD-11: 2A83]
P06239 LCK_HUMAN Myeloproliferative neoplasm [ICD-11: 2A20]
P06239 LCK_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
P06239 LCK_HUMAN Cardiovascular disease [ICD-11: BA00-BE2Z]
P06239 LCK_HUMAN Postoperative inflammation [ICD-11: 1A00-CA43]
P06239 LCK_HUMAN Gram-positive bacterial infection [ICD-11: 1B74-1F40]
P17252 KPCA_HUMAN Lung cancer [ICD-11: 2C25]
P17252 KPCA_HUMAN Muscular atrophy [ICD-11: 8B61]
P17252 KPCA_HUMAN Transplant rejection [ICD-11: NE84]
P17252 KPCA_HUMAN Nephritic syndrome [ICD-11: GB40]
P17252 KPCA_HUMAN Human immunodeficiency virus disease [ICD-11: 1C60-1C62]
P27361 MK03_HUMAN Melanoma [ICD-11: 2C30]
P27361 MK03_HUMAN Pancreatic cancer [ICD-11: 2C10]
P27361 MK03_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
P27361 MK03_HUMAN Arteries/arterioles disorder [ICD-11: BD52]
P27361 MK03_HUMAN Mature T-cell lymphoma [ICD-11: 2A90]
P28482 MK01_HUMAN Melanoma [ICD-11: 2C30]
P28482 MK01_HUMAN Pancreatic cancer [ICD-11: 2C10]
P28482 MK01_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
P28482 MK01_HUMAN Arteries/arterioles disorder [ICD-11: BD52]
P28482 MK01_HUMAN Allergic/hypersensitivity disorder [ICD-11: 4A80-4A8Z]
P28482 MK01_HUMAN Transplant rejection [ICD-11: NE84]
P28482 MK01_HUMAN Mature T-cell lymphoma [ICD-11: 2A90]
P28482 MK01_HUMAN Rheumatoid arthritis [ICD-11: FA20]
Q16539 MK14_HUMAN Chronic obstructive pulmonary disease [ICD-11: CA22]
Q16539 MK14_HUMAN Vitamin deficiency [ICD-11: 5B55-5B5F]
Q16539 MK14_HUMAN Myocardial infarction [ICD-11: BA41-BA43]
Q16539 MK14_HUMAN Coronary atherosclerosis [ICD-11: BA80]
Q16539 MK14_HUMAN Postoperative inflammation [ICD-11: 1A00-CA43]
Q16539 MK14_HUMAN Rheumatoid arthritis [ICD-11: FA20]
Q16539 MK14_HUMAN Alzheimer disease [ICD-11: 8A20]
Q16539 MK14_HUMAN Intrathoracic organs injury [ICD-11: NB32]
Q16539 MK14_HUMAN Psoriasis [ICD-11: EA90]
Q16539 MK14_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
Q16539 MK14_HUMAN Pain [ICD-11: MG30-MG3Z]
Q16539 MK14_HUMAN Retinopathy [ICD-11: 9B71]
Q96KQ7 EHMT2_HUMAN Breast cancer [ICD-11: 2C60-2C6Y]
Q96KQ7 EHMT2_HUMAN Postoperative inflammation [ICD-11: 1A00-CA43]
Q96KQ7 EHMT2_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
P10828 THB_HUMAN Hyper-lipoproteinaemia [ICD-11: 5C80]
P10828 THB_HUMAN Hypo-thyroidism [ICD-11: 5A00]
P10828 THB_HUMAN Inborn lipid metabolism error [ICD-11: 5C52]
P10828 THB_HUMAN Skin postprocedural disorder [ICD-11: EL8Y]
P10828 THB_HUMAN Thyrotoxicosis [ICD-11: 5A02]
O15530 PDPK1_HUMAN Lymphoma [ICD-11: 2A80-2A86]
O15530 PDPK1_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
P11309 PIM1_HUMAN Acute myeloid leukaemia [ICD-11: 2A60]
P11309 PIM1_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
P11309 PIM1_HUMAN Non-small cell lung cancer [ICD-11: 2C25]
P49841 GSK3B_HUMAN Myotonic disorder [ICD-11: 8C71]
P49841 GSK3B_HUMAN Acute myeloid leukaemia [ICD-11: 2A60]
P49841 GSK3B_HUMAN Fragile X chromosome [ICD-11: LD55]
P49841 GSK3B_HUMAN Myeloproliferative neoplasm [ICD-11: 2A20]
P49841 GSK3B_HUMAN Osteosarcoma [ICD-11: 2B51]
P49841 GSK3B_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
P49841 GSK3B_HUMAN Parkinsonism [ICD-11: 8A00]
P49841 GSK3B_HUMAN Allergic/hypersensitivity disorder [ICD-11: 4A80-4A8Z]
P49841 GSK3B_HUMAN Brain cancer [ICD-11: 2A00]
P49841 GSK3B_HUMAN Ovarian cancer [ICD-11: 2C73]
P49841 GSK3B_HUMAN Transplant rejection [ICD-11: NE84]
P49841 GSK3B_HUMAN Alzheimer disease [ICD-11: 8A20]
P49841 GSK3B_HUMAN Acute diabete complication [ICD-11: 5A2Y]
Q02750 MP2K1_HUMAN Lung cancer [ICD-11: 2C25]
Q02750 MP2K1_HUMAN Melanoma [ICD-11: 2C30]
Q02750 MP2K1_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
Q02750 MP2K1_HUMAN Thyroid cancer [ICD-11: 2D10]
Q02750 MP2K1_HUMAN Cardiac arrest [ICD-11: MC82]
Q96GD4 AURKB_HUMAN Acute diabete complication [ICD-11: 5A2Y]
Q96GD4 AURKB_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
Q96GD4 AURKB_HUMAN Malignant haematopoietic neoplasm [ICD-11: 2B33]
Q96GD4 AURKB_HUMAN Prostate cancer [ICD-11: 2C82]
Q96GD4 AURKB_HUMAN Acute myeloid leukaemia [ICD-11: 2A60]
Q96GD4 AURKB_HUMAN Oral cavity/oesophagus/stomach in situ carcinoma [ICD-11: 2E60]
Q96GD4 AURKB_HUMAN Prostate cancer [ICD-11: 2C82]
P42345 MTOR_HUMAN Arteries/arterioles disorder [ICD-11: BD52]
P42345 MTOR_HUMAN Chronic myelomonocytic leukaemia [ICD-11: 2A40]
P42345 MTOR_HUMAN Hydrocephalus [ICD-11: 8D64]
P42345 MTOR_HUMAN Multiple myeloma [ICD-11: 2A83]
P42345 MTOR_HUMAN Renal cell carcinoma [ICD-11: 2C90]
P42345 MTOR_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
P42345 MTOR_HUMAN Transplant rejection [ICD-11: NE84]
P42345 MTOR_HUMAN Sarcoma [ICD-11: 2A60-2C35]
P42345 MTOR_HUMAN Bladder cancer [ICD-11: 2C94]
P42345 MTOR_HUMAN Breast cancer [ICD-11: 2C60-2C6Y]
P42345 MTOR_HUMAN Endometrial cancer [ICD-11: 2C76]
P42345 MTOR_HUMAN Head and neck cancer [ICD-11: 2D42]
P42345 MTOR_HUMAN Liver cancer [ICD-11: 2C12]
P42345 MTOR_HUMAN Lung cancer [ICD-11: 2C25]
P42345 MTOR_HUMAN Malignant haematopoietic neoplasm [ICD-11: 2B33]
P42345 MTOR_HUMAN Malignant mesenchymal neoplasm [ICD-11: 2B5D-2B5Y]
P42345 MTOR_HUMAN Metastatic lymph node neoplasm [ICD-11: 2D60]
P42345 MTOR_HUMAN Pain [ICD-11: MG30-MG3Z]
P42345 MTOR_HUMAN Pancreatic cancer [ICD-11: 2C10]
P42345 MTOR_HUMAN Prostate cancer [ICD-11: 2C82]
P42345 MTOR_HUMAN Pulmonary hypertension [ICD-11: BB01]
P42345 MTOR_HUMAN Lymphangioleiomyomatosis [ICD-11: CB07]
P42345 MTOR_HUMAN Lymphoma [ICD-11: 2A80-2A86]
P42345 MTOR_HUMAN Pleural mesothelioma [ICD-11: 2C26]
P42345 MTOR_HUMAN Mature T-cell lymphoma [ICD-11: 2A90]
P42345 MTOR_HUMAN Postoperative inflammation [ICD-11: 1A00-CA43]
P42345 MTOR_HUMAN Ulcerative colitis [ICD-11: DD71]
P42345 MTOR_HUMAN Arteries/arterioles disorder [ICD-11: BD52]
P42345 MTOR_HUMAN Chronic myelomonocytic leukaemia [ICD-11: 2A40]
P42345 MTOR_HUMAN Hydrocephalus [ICD-11: 8D64]
P42345 MTOR_HUMAN Multiple myeloma [ICD-11: 2A83]
P42345 MTOR_HUMAN Renal cell carcinoma [ICD-11: 2C90]
P42345 MTOR_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
P42345 MTOR_HUMAN Transplant rejection [ICD-11: NE84]
P42345 MTOR_HUMAN Sarcoma [ICD-11: 2A60-2C35]
P42345 MTOR_HUMAN Bladder cancer [ICD-11: 2C94]
P42345 MTOR_HUMAN Breast cancer [ICD-11: 2C60-2C6Y]
P42345 MTOR_HUMAN Endometrial cancer [ICD-11: 2C76]
P42345 MTOR_HUMAN Head and neck cancer [ICD-11: 2D42]
P42345 MTOR_HUMAN Liver cancer [ICD-11: 2C12]
P42345 MTOR_HUMAN Lung cancer [ICD-11: 2C25]
P42345 MTOR_HUMAN Malignant haematopoietic neoplasm [ICD-11: 2B33]
P42345 MTOR_HUMAN Malignant mesenchymal neoplasm [ICD-11: 2B5D-2B5Y]
P42345 MTOR_HUMAN Metastatic lymph node neoplasm [ICD-11: 2D60]
P42345 MTOR_HUMAN Pain [ICD-11: MG30-MG3Z]
P42345 MTOR_HUMAN Pancreatic cancer [ICD-11: 2C10]
P42345 MTOR_HUMAN Prostate cancer [ICD-11: 2C82]
P42345 MTOR_HUMAN Pulmonary hypertension [ICD-11: BB01]
P42345 MTOR_HUMAN Lymphangioleiomyomatosis [ICD-11: CB07]
P42345 MTOR_HUMAN Lymphoma [ICD-11: 2A80-2A86]
P42345 MTOR_HUMAN Pleural mesothelioma [ICD-11: 2C26]
P42345 MTOR_HUMAN Mature T-cell lymphoma [ICD-11: 2A90]
P42345 MTOR_HUMAN Postoperative inflammation [ICD-11: 1A00-CA43]
P42345 MTOR_HUMAN Ulcerative colitis [ICD-11: DD71]
Q99814 EPAS1_HUMAN Adrenomedullary hyperfunction [ICD-11: 5A75]
Q99814 EPAS1_HUMAN Renal cell carcinoma [ICD-11: 2C90]
Q99814 EPAS1_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
Q99814 EPAS1_HUMAN Brain cancer [ICD-11: 2A00]
Q99814 EPAS1_HUMAN Adrenomedullary hyperfunction [ICD-11: 5A75]
Q99814 EPAS1_HUMAN Brain cancer [ICD-11: 2A00]
Q99814 EPAS1_HUMAN Renal cell carcinoma [ICD-11: 2C90]
P15289 ARSA_HUMAN Lysosomal disease [ICD-11: 5C56]
P45983 MK08_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
P45983 MK08_HUMAN Mature T-cell lymphoma [ICD-11: 2A90]
P45983 MK08_HUMAN Intracranial injury [ICD-11: NA07]
P10253 LYAG_HUMAN Inborn carbohydrate metabolism error [ICD-11: 5C51]
Q9NYY3 PLK2_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
P05067 A4_HUMAN Diagnostic imaging [ICD-11: N.A.]
P05067 A4_HUMAN Alzheimer disease [ICD-11: 8A20]
P05067 A4_HUMAN Desmoid tumour [ICD-11: 2F7C]
P05067 A4_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
P05067 A4_HUMAN Retinopathy [ICD-11: 9B71]
P05067 A4_HUMAN Dystrophic epidermolysis bullosa [ICD-11: EC32]
P05067 A4_HUMAN Amyloidosis [ICD-11: 5D00]
P05067 A4_HUMAN Macular degeneration [ICD-11: 9B75]
P05067 A4_HUMAN Intracranial injury [ICD-11: NA07]
P05067 A4_HUMAN Brain cancer [ICD-11: 2A00]
P05067 A4_HUMAN Dissociative neurological symptom disorder [ICD-11: 6B60]
P05067 A4_HUMAN Mild neurocognitive disorder [ICD-11: 6D71]
P42336 PK3CA_HUMAN Breast cancer [ICD-11: 2C60-2C6Y]
P42336 PK3CA_HUMAN Follicular lymphoma [ICD-11: 2A80]
P42336 PK3CA_HUMAN Malignant haematopoietic neoplasm [ICD-11: 2B33]
P42336 PK3CA_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
P42336 PK3CA_HUMAN Prostate cancer [ICD-11: 2C82]
P42336 PK3CA_HUMAN Colorectal cancer [ICD-11: 2B91]
P42336 PK3CA_HUMAN Rheumatoid arthritis [ICD-11: FA20]
P42336 PK3CA_HUMAN Breast cancer [ICD-11: 2C60-2C6Y]
P42336 PK3CA_HUMAN Follicular lymphoma [ICD-11: 2A80]
P42336 PK3CA_HUMAN Malignant haematopoietic neoplasm [ICD-11: 2B33]
P42336 PK3CA_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
P42336 PK3CA_HUMAN Prostate cancer [ICD-11: 2C82]
P42336 PK3CA_HUMAN Colorectal cancer [ICD-11: 2B91]
P42336 PK3CA_HUMAN Rheumatoid arthritis [ICD-11: FA20]
P42336 PK3CA_HUMAN Breast cancer [ICD-11: 2C60-2C6Y]
P42336 PK3CA_HUMAN Follicular lymphoma [ICD-11: 2A80]
P42336 PK3CA_HUMAN Malignant haematopoietic neoplasm [ICD-11: 2B33]
P42336 PK3CA_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
P42336 PK3CA_HUMAN Prostate cancer [ICD-11: 2C82]
P42336 PK3CA_HUMAN Colorectal cancer [ICD-11: 2B91]
P42336 PK3CA_HUMAN Rheumatoid arthritis [ICD-11: FA20]
P42336 PK3CA_HUMAN Breast cancer [ICD-11: 2C60-2C6Y]
P42336 PK3CA_HUMAN Follicular lymphoma [ICD-11: 2A80]
P42336 PK3CA_HUMAN Malignant haematopoietic neoplasm [ICD-11: 2B33]
P42336 PK3CA_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
P42336 PK3CA_HUMAN Prostate cancer [ICD-11: 2C82]
P42336 PK3CA_HUMAN Colorectal cancer [ICD-11: 2B91]
P42336 PK3CA_HUMAN Rheumatoid arthritis [ICD-11: FA20]
P42336 PK3CA_HUMAN Breast cancer [ICD-11: 2C60-2C6Y]
P42336 PK3CA_HUMAN Follicular lymphoma [ICD-11: 2A80]
P42336 PK3CA_HUMAN Malignant haematopoietic neoplasm [ICD-11: 2B33]
P42336 PK3CA_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
P42336 PK3CA_HUMAN Prostate cancer [ICD-11: 2C82]
P42336 PK3CA_HUMAN Colorectal cancer [ICD-11: 2B91]
P42336 PK3CA_HUMAN Rheumatoid arthritis [ICD-11: FA20]
P42336 PK3CA_HUMAN Breast cancer [ICD-11: 2C60-2C6Y]
P42336 PK3CA_HUMAN Follicular lymphoma [ICD-11: 2A80]
P42336 PK3CA_HUMAN Malignant haematopoietic neoplasm [ICD-11: 2B33]
P42336 PK3CA_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
P42336 PK3CA_HUMAN Prostate cancer [ICD-11: 2C82]
P42336 PK3CA_HUMAN Colorectal cancer [ICD-11: 2B91]
P42336 PK3CA_HUMAN Rheumatoid arthritis [ICD-11: FA20]
P42336 PK3CA_HUMAN Breast cancer [ICD-11: 2C60-2C6Y]
P42336 PK3CA_HUMAN Follicular lymphoma [ICD-11: 2A80]
P42336 PK3CA_HUMAN Malignant haematopoietic neoplasm [ICD-11: 2B33]
P42336 PK3CA_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
P42336 PK3CA_HUMAN Prostate cancer [ICD-11: 2C82]
P42336 PK3CA_HUMAN Colorectal cancer [ICD-11: 2B91]
P42336 PK3CA_HUMAN Rheumatoid arthritis [ICD-11: FA20]
P42336 PK3CA_HUMAN Breast cancer [ICD-11: 2C60-2C6Y]
P42336 PK3CA_HUMAN Follicular lymphoma [ICD-11: 2A80]
P42336 PK3CA_HUMAN Malignant haematopoietic neoplasm [ICD-11: 2B33]
P42336 PK3CA_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
P42336 PK3CA_HUMAN Prostate cancer [ICD-11: 2C82]
P42336 PK3CA_HUMAN Colorectal cancer [ICD-11: 2B91]
P42336 PK3CA_HUMAN Rheumatoid arthritis [ICD-11: FA20]
P42336 PK3CA_HUMAN Breast cancer [ICD-11: 2C60-2C6Y]
P42336 PK3CA_HUMAN Follicular lymphoma [ICD-11: 2A80]
P42336 PK3CA_HUMAN Malignant haematopoietic neoplasm [ICD-11: 2B33]
P42336 PK3CA_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
P42336 PK3CA_HUMAN Prostate cancer [ICD-11: 2C82]
P42336 PK3CA_HUMAN Colorectal cancer [ICD-11: 2B91]
P42336 PK3CA_HUMAN Rheumatoid arthritis [ICD-11: FA20]
P48736 PK3CG_HUMAN Follicular lymphoma [ICD-11: 2A80]
P48736 PK3CG_HUMAN Malignant haematopoietic neoplasm [ICD-11: 2B33]
P48736 PK3CG_HUMAN Mature B-cell leukaemia [ICD-11: 2A82]
P48736 PK3CG_HUMAN Rheumatoid arthritis [ICD-11: FA20]
P48736 PK3CG_HUMAN Brain cancer [ICD-11: 2A00]
P48736 PK3CG_HUMAN Breast cancer [ICD-11: 2C60-2C6Y]
P48736 PK3CG_HUMAN Central nervous system disease [ICD-11: 8A04-8D87]
P48736 PK3CG_HUMAN Diffuse large B-cell lymphoma [ICD-11: 2A81]
P48736 PK3CG_HUMAN Myelodysplastic syndrome [ICD-11: 2A37]
P48736 PK3CG_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
P48736 PK3CG_HUMAN Adrenal cancer [ICD-11: 2D11]
P48736 PK3CG_HUMAN Bladder cancer [ICD-11: 2C94]
P48736 PK3CG_HUMAN Endometrial cancer [ICD-11: 2C76]
P48736 PK3CG_HUMAN Head and neck cancer [ICD-11: 2D42]
P48736 PK3CG_HUMAN Liver cancer [ICD-11: 2C12]
P48736 PK3CG_HUMAN Melanoma [ICD-11: 2C30]
P48736 PK3CG_HUMAN Metastatic lymph node neoplasm [ICD-11: 2D60]
P48736 PK3CG_HUMAN Pain [ICD-11: MG30-MG3Z]
P48736 PK3CG_HUMAN Peritoneal cancer [ICD-11: 2C51]
P48736 PK3CG_HUMAN BCR-ABL1-negative chronic myeloid leukaemia [ICD-11: 2A41]
P48736 PK3CG_HUMAN Colorectal cancer [ICD-11: 2B91]
P48736 PK3CG_HUMAN Innate/adaptive immunodeficiency [ICD-11: 4A00]
P48736 PK3CG_HUMAN Myocardial infarction [ICD-11: BA41-BA43]
P48736 PK3CG_HUMAN B-cell lymphoma [ICD-11: 2A86]
P48736 PK3CG_HUMAN Lymphoma [ICD-11: 2A80-2A86]
P48736 PK3CG_HUMAN Pleural mesothelioma [ICD-11: 2C26]
P48736 PK3CG_HUMAN Type 2 diabetes mellitus [ICD-11: 5A11]
P48736 PK3CG_HUMAN Cardiovascular disease [ICD-11: BA00-BE2Z]
P48736 PK3CG_HUMAN Bacterial infection [ICD-11: 1A00-1C4Z]
P48736 PK3CG_HUMAN Postoperative inflammation [ICD-11: 1A00-CA43]
P48736 PK3CG_HUMAN Prostate cancer [ICD-11: 2C82]
P48736 PK3CG_HUMAN Follicular lymphoma [ICD-11: 2A80]
P48736 PK3CG_HUMAN Malignant haematopoietic neoplasm [ICD-11: 2B33]
P48736 PK3CG_HUMAN Mature B-cell leukaemia [ICD-11: 2A82]
P48736 PK3CG_HUMAN Rheumatoid arthritis [ICD-11: FA20]
P48736 PK3CG_HUMAN Brain cancer [ICD-11: 2A00]
P48736 PK3CG_HUMAN Breast cancer [ICD-11: 2C60-2C6Y]
P48736 PK3CG_HUMAN Central nervous system disease [ICD-11: 8A04-8D87]
P48736 PK3CG_HUMAN Diffuse large B-cell lymphoma [ICD-11: 2A81]
P48736 PK3CG_HUMAN Myelodysplastic syndrome [ICD-11: 2A37]
P48736 PK3CG_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
P48736 PK3CG_HUMAN Adrenal cancer [ICD-11: 2D11]
P48736 PK3CG_HUMAN Bladder cancer [ICD-11: 2C94]
P48736 PK3CG_HUMAN Endometrial cancer [ICD-11: 2C76]
P48736 PK3CG_HUMAN Head and neck cancer [ICD-11: 2D42]
P48736 PK3CG_HUMAN Liver cancer [ICD-11: 2C12]
P48736 PK3CG_HUMAN Melanoma [ICD-11: 2C30]
P48736 PK3CG_HUMAN Metastatic lymph node neoplasm [ICD-11: 2D60]
P48736 PK3CG_HUMAN Pain [ICD-11: MG30-MG3Z]
P48736 PK3CG_HUMAN Peritoneal cancer [ICD-11: 2C51]
P48736 PK3CG_HUMAN BCR-ABL1-negative chronic myeloid leukaemia [ICD-11: 2A41]
P48736 PK3CG_HUMAN Colorectal cancer [ICD-11: 2B91]
P48736 PK3CG_HUMAN Innate/adaptive immunodeficiency [ICD-11: 4A00]
P48736 PK3CG_HUMAN Myocardial infarction [ICD-11: BA41-BA43]
P48736 PK3CG_HUMAN B-cell lymphoma [ICD-11: 2A86]
P48736 PK3CG_HUMAN Lymphoma [ICD-11: 2A80-2A86]
P48736 PK3CG_HUMAN Pleural mesothelioma [ICD-11: 2C26]
P48736 PK3CG_HUMAN Type 2 diabetes mellitus [ICD-11: 5A11]
P48736 PK3CG_HUMAN Cardiovascular disease [ICD-11: BA00-BE2Z]
P48736 PK3CG_HUMAN Bacterial infection [ICD-11: 1A00-1C4Z]
P48736 PK3CG_HUMAN Postoperative inflammation [ICD-11: 1A00-CA43]
P48736 PK3CG_HUMAN Prostate cancer [ICD-11: 2C82]
P48736 PK3CG_HUMAN Follicular lymphoma [ICD-11: 2A80]
P48736 PK3CG_HUMAN Malignant haematopoietic neoplasm [ICD-11: 2B33]
P48736 PK3CG_HUMAN Mature B-cell leukaemia [ICD-11: 2A82]
P48736 PK3CG_HUMAN Rheumatoid arthritis [ICD-11: FA20]
P48736 PK3CG_HUMAN Brain cancer [ICD-11: 2A00]
P48736 PK3CG_HUMAN Breast cancer [ICD-11: 2C60-2C6Y]
P48736 PK3CG_HUMAN Central nervous system disease [ICD-11: 8A04-8D87]
P48736 PK3CG_HUMAN Diffuse large B-cell lymphoma [ICD-11: 2A81]
P48736 PK3CG_HUMAN Myelodysplastic syndrome [ICD-11: 2A37]
P48736 PK3CG_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
P48736 PK3CG_HUMAN Adrenal cancer [ICD-11: 2D11]
P48736 PK3CG_HUMAN Bladder cancer [ICD-11: 2C94]
P48736 PK3CG_HUMAN Endometrial cancer [ICD-11: 2C76]
P48736 PK3CG_HUMAN Head and neck cancer [ICD-11: 2D42]
P48736 PK3CG_HUMAN Liver cancer [ICD-11: 2C12]
P48736 PK3CG_HUMAN Melanoma [ICD-11: 2C30]
P48736 PK3CG_HUMAN Metastatic lymph node neoplasm [ICD-11: 2D60]
P48736 PK3CG_HUMAN Pain [ICD-11: MG30-MG3Z]
P48736 PK3CG_HUMAN Peritoneal cancer [ICD-11: 2C51]
P48736 PK3CG_HUMAN BCR-ABL1-negative chronic myeloid leukaemia [ICD-11: 2A41]
P48736 PK3CG_HUMAN Colorectal cancer [ICD-11: 2B91]
P48736 PK3CG_HUMAN Innate/adaptive immunodeficiency [ICD-11: 4A00]
P48736 PK3CG_HUMAN Myocardial infarction [ICD-11: BA41-BA43]
P48736 PK3CG_HUMAN B-cell lymphoma [ICD-11: 2A86]
P48736 PK3CG_HUMAN Lymphoma [ICD-11: 2A80-2A86]
P48736 PK3CG_HUMAN Pleural mesothelioma [ICD-11: 2C26]
P48736 PK3CG_HUMAN Type 2 diabetes mellitus [ICD-11: 5A11]
P48736 PK3CG_HUMAN Cardiovascular disease [ICD-11: BA00-BE2Z]
P48736 PK3CG_HUMAN Bacterial infection [ICD-11: 1A00-1C4Z]
P48736 PK3CG_HUMAN Postoperative inflammation [ICD-11: 1A00-CA43]
P48736 PK3CG_HUMAN Prostate cancer [ICD-11: 2C82]
P48736 PK3CG_HUMAN Follicular lymphoma [ICD-11: 2A80]
P48736 PK3CG_HUMAN Malignant haematopoietic neoplasm [ICD-11: 2B33]
P48736 PK3CG_HUMAN Mature B-cell leukaemia [ICD-11: 2A82]
P48736 PK3CG_HUMAN Rheumatoid arthritis [ICD-11: FA20]
P48736 PK3CG_HUMAN Brain cancer [ICD-11: 2A00]
P48736 PK3CG_HUMAN Breast cancer [ICD-11: 2C60-2C6Y]
P48736 PK3CG_HUMAN Central nervous system disease [ICD-11: 8A04-8D87]
P48736 PK3CG_HUMAN Diffuse large B-cell lymphoma [ICD-11: 2A81]
P48736 PK3CG_HUMAN Myelodysplastic syndrome [ICD-11: 2A37]
P48736 PK3CG_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
P48736 PK3CG_HUMAN Adrenal cancer [ICD-11: 2D11]
P48736 PK3CG_HUMAN Bladder cancer [ICD-11: 2C94]
P48736 PK3CG_HUMAN Endometrial cancer [ICD-11: 2C76]
P48736 PK3CG_HUMAN Head and neck cancer [ICD-11: 2D42]
P48736 PK3CG_HUMAN Liver cancer [ICD-11: 2C12]
P48736 PK3CG_HUMAN Melanoma [ICD-11: 2C30]
P48736 PK3CG_HUMAN Metastatic lymph node neoplasm [ICD-11: 2D60]
P48736 PK3CG_HUMAN Pain [ICD-11: MG30-MG3Z]
P48736 PK3CG_HUMAN Peritoneal cancer [ICD-11: 2C51]
P48736 PK3CG_HUMAN BCR-ABL1-negative chronic myeloid leukaemia [ICD-11: 2A41]
P48736 PK3CG_HUMAN Colorectal cancer [ICD-11: 2B91]
P48736 PK3CG_HUMAN Innate/adaptive immunodeficiency [ICD-11: 4A00]
P48736 PK3CG_HUMAN Myocardial infarction [ICD-11: BA41-BA43]
P48736 PK3CG_HUMAN B-cell lymphoma [ICD-11: 2A86]
P48736 PK3CG_HUMAN Lymphoma [ICD-11: 2A80-2A86]
P48736 PK3CG_HUMAN Pleural mesothelioma [ICD-11: 2C26]
P48736 PK3CG_HUMAN Type 2 diabetes mellitus [ICD-11: 5A11]
P48736 PK3CG_HUMAN Cardiovascular disease [ICD-11: BA00-BE2Z]
P48736 PK3CG_HUMAN Bacterial infection [ICD-11: 1A00-1C4Z]
P48736 PK3CG_HUMAN Postoperative inflammation [ICD-11: 1A00-CA43]
P48736 PK3CG_HUMAN Prostate cancer [ICD-11: 2C82]
P48736 PK3CG_HUMAN Follicular lymphoma [ICD-11: 2A80]
P48736 PK3CG_HUMAN Malignant haematopoietic neoplasm [ICD-11: 2B33]
P48736 PK3CG_HUMAN Mature B-cell leukaemia [ICD-11: 2A82]
P48736 PK3CG_HUMAN Rheumatoid arthritis [ICD-11: FA20]
P48736 PK3CG_HUMAN Brain cancer [ICD-11: 2A00]
P48736 PK3CG_HUMAN Breast cancer [ICD-11: 2C60-2C6Y]
P48736 PK3CG_HUMAN Central nervous system disease [ICD-11: 8A04-8D87]
P48736 PK3CG_HUMAN Diffuse large B-cell lymphoma [ICD-11: 2A81]
P48736 PK3CG_HUMAN Myelodysplastic syndrome [ICD-11: 2A37]
P48736 PK3CG_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
P48736 PK3CG_HUMAN Adrenal cancer [ICD-11: 2D11]
P48736 PK3CG_HUMAN Bladder cancer [ICD-11: 2C94]
P48736 PK3CG_HUMAN Endometrial cancer [ICD-11: 2C76]
P48736 PK3CG_HUMAN Head and neck cancer [ICD-11: 2D42]
P48736 PK3CG_HUMAN Liver cancer [ICD-11: 2C12]
P48736 PK3CG_HUMAN Melanoma [ICD-11: 2C30]
P48736 PK3CG_HUMAN Metastatic lymph node neoplasm [ICD-11: 2D60]
P48736 PK3CG_HUMAN Pain [ICD-11: MG30-MG3Z]
P48736 PK3CG_HUMAN Peritoneal cancer [ICD-11: 2C51]
P48736 PK3CG_HUMAN BCR-ABL1-negative chronic myeloid leukaemia [ICD-11: 2A41]
P48736 PK3CG_HUMAN Colorectal cancer [ICD-11: 2B91]
P48736 PK3CG_HUMAN Innate/adaptive immunodeficiency [ICD-11: 4A00]
P48736 PK3CG_HUMAN Myocardial infarction [ICD-11: BA41-BA43]
P48736 PK3CG_HUMAN B-cell lymphoma [ICD-11: 2A86]
P48736 PK3CG_HUMAN Lymphoma [ICD-11: 2A80-2A86]
P48736 PK3CG_HUMAN Pleural mesothelioma [ICD-11: 2C26]
P48736 PK3CG_HUMAN Type 2 diabetes mellitus [ICD-11: 5A11]
P48736 PK3CG_HUMAN Cardiovascular disease [ICD-11: BA00-BE2Z]
P48736 PK3CG_HUMAN Bacterial infection [ICD-11: 1A00-1C4Z]
P48736 PK3CG_HUMAN Postoperative inflammation [ICD-11: 1A00-CA43]
P48736 PK3CG_HUMAN Prostate cancer [ICD-11: 2C82]
P48736 PK3CG_HUMAN Follicular lymphoma [ICD-11: 2A80]
P48736 PK3CG_HUMAN Malignant haematopoietic neoplasm [ICD-11: 2B33]
P48736 PK3CG_HUMAN Mature B-cell leukaemia [ICD-11: 2A82]
P48736 PK3CG_HUMAN Rheumatoid arthritis [ICD-11: FA20]
P48736 PK3CG_HUMAN Brain cancer [ICD-11: 2A00]
P48736 PK3CG_HUMAN Breast cancer [ICD-11: 2C60-2C6Y]
P48736 PK3CG_HUMAN Central nervous system disease [ICD-11: 8A04-8D87]
P48736 PK3CG_HUMAN Diffuse large B-cell lymphoma [ICD-11: 2A81]
P48736 PK3CG_HUMAN Myelodysplastic syndrome [ICD-11: 2A37]
P48736 PK3CG_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
P48736 PK3CG_HUMAN Adrenal cancer [ICD-11: 2D11]
P48736 PK3CG_HUMAN Bladder cancer [ICD-11: 2C94]
P48736 PK3CG_HUMAN Endometrial cancer [ICD-11: 2C76]
P48736 PK3CG_HUMAN Head and neck cancer [ICD-11: 2D42]
P48736 PK3CG_HUMAN Liver cancer [ICD-11: 2C12]
P48736 PK3CG_HUMAN Melanoma [ICD-11: 2C30]
P48736 PK3CG_HUMAN Metastatic lymph node neoplasm [ICD-11: 2D60]
P48736 PK3CG_HUMAN Pain [ICD-11: MG30-MG3Z]
P48736 PK3CG_HUMAN Peritoneal cancer [ICD-11: 2C51]
P48736 PK3CG_HUMAN BCR-ABL1-negative chronic myeloid leukaemia [ICD-11: 2A41]
P48736 PK3CG_HUMAN Colorectal cancer [ICD-11: 2B91]
P48736 PK3CG_HUMAN Innate/adaptive immunodeficiency [ICD-11: 4A00]
P48736 PK3CG_HUMAN Myocardial infarction [ICD-11: BA41-BA43]
P48736 PK3CG_HUMAN B-cell lymphoma [ICD-11: 2A86]
P48736 PK3CG_HUMAN Lymphoma [ICD-11: 2A80-2A86]
P48736 PK3CG_HUMAN Pleural mesothelioma [ICD-11: 2C26]
P48736 PK3CG_HUMAN Type 2 diabetes mellitus [ICD-11: 5A11]
P48736 PK3CG_HUMAN Cardiovascular disease [ICD-11: BA00-BE2Z]
P48736 PK3CG_HUMAN Bacterial infection [ICD-11: 1A00-1C4Z]
P48736 PK3CG_HUMAN Postoperative inflammation [ICD-11: 1A00-CA43]
P48736 PK3CG_HUMAN Prostate cancer [ICD-11: 2C82]
P48736 PK3CG_HUMAN Follicular lymphoma [ICD-11: 2A80]
P48736 PK3CG_HUMAN Malignant haematopoietic neoplasm [ICD-11: 2B33]
P48736 PK3CG_HUMAN Mature B-cell leukaemia [ICD-11: 2A82]
P48736 PK3CG_HUMAN Rheumatoid arthritis [ICD-11: FA20]
P48736 PK3CG_HUMAN Brain cancer [ICD-11: 2A00]
P48736 PK3CG_HUMAN Breast cancer [ICD-11: 2C60-2C6Y]
P48736 PK3CG_HUMAN Central nervous system disease [ICD-11: 8A04-8D87]
P48736 PK3CG_HUMAN Diffuse large B-cell lymphoma [ICD-11: 2A81]
P48736 PK3CG_HUMAN Myelodysplastic syndrome [ICD-11: 2A37]
P48736 PK3CG_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
P48736 PK3CG_HUMAN Adrenal cancer [ICD-11: 2D11]
P48736 PK3CG_HUMAN Bladder cancer [ICD-11: 2C94]
P48736 PK3CG_HUMAN Endometrial cancer [ICD-11: 2C76]
P48736 PK3CG_HUMAN Head and neck cancer [ICD-11: 2D42]
P48736 PK3CG_HUMAN Liver cancer [ICD-11: 2C12]
P48736 PK3CG_HUMAN Melanoma [ICD-11: 2C30]
P48736 PK3CG_HUMAN Metastatic lymph node neoplasm [ICD-11: 2D60]
P48736 PK3CG_HUMAN Pain [ICD-11: MG30-MG3Z]
P48736 PK3CG_HUMAN Peritoneal cancer [ICD-11: 2C51]
P48736 PK3CG_HUMAN BCR-ABL1-negative chronic myeloid leukaemia [ICD-11: 2A41]
P48736 PK3CG_HUMAN Colorectal cancer [ICD-11: 2B91]
P48736 PK3CG_HUMAN Innate/adaptive immunodeficiency [ICD-11: 4A00]
P48736 PK3CG_HUMAN Myocardial infarction [ICD-11: BA41-BA43]
P48736 PK3CG_HUMAN B-cell lymphoma [ICD-11: 2A86]
P48736 PK3CG_HUMAN Lymphoma [ICD-11: 2A80-2A86]
P48736 PK3CG_HUMAN Pleural mesothelioma [ICD-11: 2C26]
P48736 PK3CG_HUMAN Type 2 diabetes mellitus [ICD-11: 5A11]
P48736 PK3CG_HUMAN Cardiovascular disease [ICD-11: BA00-BE2Z]
P48736 PK3CG_HUMAN Bacterial infection [ICD-11: 1A00-1C4Z]
P48736 PK3CG_HUMAN Postoperative inflammation [ICD-11: 1A00-CA43]
P48736 PK3CG_HUMAN Prostate cancer [ICD-11: 2C82]
P49137 MAPK2_HUMAN Peritoneal cancer [ICD-11: 2C51]
P49137 MAPK2_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
P49137 MAPK2_HUMAN Acute laryngitis/tracheitis [ICD-11: CA05]
P49137 MAPK2_HUMAN Fibrosis [ICD-11: GA14-GC01]
Q13627 DYR1A_HUMAN Cytomegaloviral disease [ICD-11: 1D82]
O14920 IKKB_HUMAN Mature B-cell lymphoma [ICD-11: 2A85]
O14920 IKKB_HUMAN Alzheimer disease [ICD-11: 8A20]
O14920 IKKB_HUMAN Osteoarthritis [ICD-11: FA00-FA05]
O14920 IKKB_HUMAN Acne vulgaris [ICD-11: ED80]
O14920 IKKB_HUMAN Rheumatoid arthritis [ICD-11: FA20]
P24941 CDK2_HUMAN Lung cancer [ICD-11: 2C25]
P24941 CDK2_HUMAN Nasopharyngeal cancer [ICD-11: 2B6B]
P24941 CDK2_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
P24941 CDK2_HUMAN Thymoma [ICD-11: 2C27]
P24941 CDK2_HUMAN Brain cancer [ICD-11: 2A00]
P24941 CDK2_HUMAN Breast cancer [ICD-11: 2C60-2C6Y]
P24941 CDK2_HUMAN Lymphoma [ICD-11: 2A80-2A86]
P24941 CDK2_HUMAN Malignant haematopoietic neoplasm [ICD-11: 2B33]
P24941 CDK2_HUMAN Non-small cell lung cancer [ICD-11: 2C25]
P24941 CDK2_HUMAN Mature B-cell lymphoma [ICD-11: 2A85]
P24941 CDK2_HUMAN Obesity [ICD-11: 5B80-5B81]
P24941 CDK2_HUMAN Retina cancer [ICD-11: 2D02]
Q15118 PDK1_HUMAN Idiopathic interstitial pneumonitis [ICD-11: CB03]
Q15118 PDK1_HUMAN Inborn energy metabolism error [ICD-11: 5C53]
Q15118 PDK1_HUMAN Insulin-resistance syndrome [ICD-11: 5A44]
Q15118 PDK1_HUMAN Metastatic tumour [ICD-11: 2D50-2E2Z]
Q15118 PDK1_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
O14757 CHK1_HUMAN Anal cancer [ICD-11: 2C00]
O14757 CHK1_HUMAN Head and neck cancer [ICD-11: 2D42]
O14757 CHK1_HUMAN Lung cancer [ICD-11: 2C25]
O14757 CHK1_HUMAN Ovarian cancer [ICD-11: 2C73]
O14757 CHK1_HUMAN Pancreatic cancer [ICD-11: 2C10]
O14757 CHK1_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
O14757 CHK1_HUMAN Hodgkin lymphoma [ICD-11: 2B30]
O14757 CHK1_HUMAN Lymphoma [ICD-11: 2A80-2A86]
O14757 CHK1_HUMAN Breast cancer [ICD-11: 2C60-2C6Y]
Q05513 KPCZ_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
O00141 SGK1_HUMAN Prostate cancer [ICD-11: 2C82]
O00329 PK3CD_HUMAN Diffuse large B-cell lymphoma [ICD-11: 2A81]
O00329 PK3CD_HUMAN Follicular lymphoma [ICD-11: 2A80]
O00329 PK3CD_HUMAN Malignant haematopoietic neoplasm [ICD-11: 2B33]
O00329 PK3CD_HUMAN Mature B-cell leukaemia [ICD-11: 2A82]
O00329 PK3CD_HUMAN Mature B-cell lymphoma [ICD-11: 2A85]
O00329 PK3CD_HUMAN Rheumatoid arthritis [ICD-11: FA20]
O00329 PK3CD_HUMAN Breast cancer [ICD-11: 2C60-2C6Y]
O00329 PK3CD_HUMAN Mycosis fungoides [ICD-11: 2B01]
O00329 PK3CD_HUMAN Sjogren syndrome [ICD-11: 4A43]
O00329 PK3CD_HUMAN Colorectal cancer [ICD-11: 2B91]
O00329 PK3CD_HUMAN Lymphoma [ICD-11: 2A80-2A86]
O00329 PK3CD_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
O00329 PK3CD_HUMAN B-cell lymphoma [ICD-11: 2A86]
O00329 PK3CD_HUMAN Diffuse large B-cell lymphoma [ICD-11: 2A81]
O00329 PK3CD_HUMAN Follicular lymphoma [ICD-11: 2A80]
O00329 PK3CD_HUMAN Malignant haematopoietic neoplasm [ICD-11: 2B33]
O00329 PK3CD_HUMAN Mature B-cell leukaemia [ICD-11: 2A82]
O00329 PK3CD_HUMAN Mature B-cell lymphoma [ICD-11: 2A85]
O00329 PK3CD_HUMAN Rheumatoid arthritis [ICD-11: FA20]
O00329 PK3CD_HUMAN Breast cancer [ICD-11: 2C60-2C6Y]
O00329 PK3CD_HUMAN Mycosis fungoides [ICD-11: 2B01]
O00329 PK3CD_HUMAN Sjogren syndrome [ICD-11: 4A43]
O00329 PK3CD_HUMAN Colorectal cancer [ICD-11: 2B91]
O00329 PK3CD_HUMAN Lymphoma [ICD-11: 2A80-2A86]
O00329 PK3CD_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
O00329 PK3CD_HUMAN B-cell lymphoma [ICD-11: 2A86]
O00329 PK3CD_HUMAN Diffuse large B-cell lymphoma [ICD-11: 2A81]
O00329 PK3CD_HUMAN Follicular lymphoma [ICD-11: 2A80]
O00329 PK3CD_HUMAN Malignant haematopoietic neoplasm [ICD-11: 2B33]
O00329 PK3CD_HUMAN Mature B-cell leukaemia [ICD-11: 2A82]
O00329 PK3CD_HUMAN Mature B-cell lymphoma [ICD-11: 2A85]
O00329 PK3CD_HUMAN Rheumatoid arthritis [ICD-11: FA20]
O00329 PK3CD_HUMAN Breast cancer [ICD-11: 2C60-2C6Y]
O00329 PK3CD_HUMAN Mycosis fungoides [ICD-11: 2B01]
O00329 PK3CD_HUMAN Sjogren syndrome [ICD-11: 4A43]
O00329 PK3CD_HUMAN Colorectal cancer [ICD-11: 2B91]
O00329 PK3CD_HUMAN Lymphoma [ICD-11: 2A80-2A86]
O00329 PK3CD_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
O00329 PK3CD_HUMAN B-cell lymphoma [ICD-11: 2A86]
O00329 PK3CD_HUMAN Diffuse large B-cell lymphoma [ICD-11: 2A81]
O00329 PK3CD_HUMAN Follicular lymphoma [ICD-11: 2A80]
O00329 PK3CD_HUMAN Malignant haematopoietic neoplasm [ICD-11: 2B33]
O00329 PK3CD_HUMAN Mature B-cell leukaemia [ICD-11: 2A82]
O00329 PK3CD_HUMAN Mature B-cell lymphoma [ICD-11: 2A85]
O00329 PK3CD_HUMAN Rheumatoid arthritis [ICD-11: FA20]
O00329 PK3CD_HUMAN Breast cancer [ICD-11: 2C60-2C6Y]
O00329 PK3CD_HUMAN Mycosis fungoides [ICD-11: 2B01]
O00329 PK3CD_HUMAN Sjogren syndrome [ICD-11: 4A43]
O00329 PK3CD_HUMAN Colorectal cancer [ICD-11: 2B91]
O00329 PK3CD_HUMAN Lymphoma [ICD-11: 2A80-2A86]
O00329 PK3CD_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
O00329 PK3CD_HUMAN B-cell lymphoma [ICD-11: 2A86]
O00418 EF2K_HUMAN Breast cancer [ICD-11: 2C60-2C6Y]
O75116 ROCK2_HUMAN Lupus erythematosus [ICD-11: 4A40]
O75116 ROCK2_HUMAN Psoriasis [ICD-11: EA90]
O75116 ROCK2_HUMAN Psoriatic arthritis [ICD-11: FA21]
O75116 ROCK2_HUMAN Rheumatoid arthritis [ICD-11: FA20]
O75116 ROCK2_HUMAN Systemic sclerosis [ICD-11: 4A42]
O75116 ROCK2_HUMAN Glaucoma [ICD-11: 9C61]
O75116 ROCK2_HUMAN Postoperative inflammation [ICD-11: 1A00-CA43]
O75116 ROCK2_HUMAN Chronic obstructive pulmonary disease [ICD-11: CA22]
O75116 ROCK2_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
O96013 PAK4_HUMAN Malignant haematopoietic neoplasm [ICD-11: 2B33]
O96013 PAK4_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
O96017 CHK2_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
P23443 KS6B1_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
P23443 KS6B1_HUMAN Ulcerative colitis [ICD-11: DD71]
P27448 MARK3_HUMAN Peritoneal cancer [ICD-11: 2C51]
P27448 MARK3_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
P42338 PK3CB_HUMAN Breast cancer [ICD-11: 2C60-2C6Y]
P42338 PK3CB_HUMAN Metastatic lymph node neoplasm [ICD-11: 2D60]
P42338 PK3CB_HUMAN Pain [ICD-11: MG30-MG3Z]
P42338 PK3CB_HUMAN Colorectal cancer [ICD-11: 2B91]
P42338 PK3CB_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
P42338 PK3CB_HUMAN Prostate cancer [ICD-11: 2C82]
P42338 PK3CB_HUMAN Thrombosis [ICD-11: DB61-GB90]
P42338 PK3CB_HUMAN Breast cancer [ICD-11: 2C60-2C6Y]
P42338 PK3CB_HUMAN Metastatic lymph node neoplasm [ICD-11: 2D60]
P42338 PK3CB_HUMAN Pain [ICD-11: MG30-MG3Z]
P42338 PK3CB_HUMAN Colorectal cancer [ICD-11: 2B91]
P42338 PK3CB_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
P42338 PK3CB_HUMAN Prostate cancer [ICD-11: 2C82]
P42338 PK3CB_HUMAN Thrombosis [ICD-11: DB61-GB90]
P42338 PK3CB_HUMAN Breast cancer [ICD-11: 2C60-2C6Y]
P42338 PK3CB_HUMAN Metastatic lymph node neoplasm [ICD-11: 2D60]
P42338 PK3CB_HUMAN Pain [ICD-11: MG30-MG3Z]
P42338 PK3CB_HUMAN Colorectal cancer [ICD-11: 2B91]
P42338 PK3CB_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
P42338 PK3CB_HUMAN Prostate cancer [ICD-11: 2C82]
P42338 PK3CB_HUMAN Thrombosis [ICD-11: DB61-GB90]
P42338 PK3CB_HUMAN Breast cancer [ICD-11: 2C60-2C6Y]
P42338 PK3CB_HUMAN Metastatic lymph node neoplasm [ICD-11: 2D60]
P42338 PK3CB_HUMAN Pain [ICD-11: MG30-MG3Z]
P42338 PK3CB_HUMAN Colorectal cancer [ICD-11: 2B91]
P42338 PK3CB_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
P42338 PK3CB_HUMAN Prostate cancer [ICD-11: 2C82]
P42338 PK3CB_HUMAN Thrombosis [ICD-11: DB61-GB90]
P42338 PK3CB_HUMAN Breast cancer [ICD-11: 2C60-2C6Y]
P42338 PK3CB_HUMAN Metastatic lymph node neoplasm [ICD-11: 2D60]
P42338 PK3CB_HUMAN Pain [ICD-11: MG30-MG3Z]
P42338 PK3CB_HUMAN Colorectal cancer [ICD-11: 2B91]
P42338 PK3CB_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
P42338 PK3CB_HUMAN Prostate cancer [ICD-11: 2C82]
P42338 PK3CB_HUMAN Thrombosis [ICD-11: DB61-GB90]
P45984 MK09_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
P45984 MK09_HUMAN Mature T-cell lymphoma [ICD-11: 2A90]
P48730 KC1D_HUMAN Mature B-cell leukaemia [ICD-11: 2A82]
P48730 KC1D_HUMAN Pancreatic cancer [ICD-11: 2C10]
P51812 KS6A3_HUMAN Mature B-cell leukaemia [ICD-11: 2A82]
P53778 MK12_HUMAN Chronic kidney disease [ICD-11: GB61]
P53778 MK12_HUMAN Lupus erythematosus [ICD-11: 4A40]
P53778 MK12_HUMAN Thrombocytopenia [ICD-11: 3B64]
P53778 MK12_HUMAN Alzheimer disease [ICD-11: 8A20]
P53778 MK12_HUMAN Cardiomyopathy [ICD-11: BC43]
P53778 MK12_HUMAN Osteoarthritis [ICD-11: FA00-FA05]
P53778 MK12_HUMAN Pain [ICD-11: MG30-MG3Z]
P53778 MK12_HUMAN Rheumatoid arthritis [ICD-11: FA20]
P53778 MK12_HUMAN Cardiovascular disease [ICD-11: BA00-BE2Z]
P53778 MK12_HUMAN Indeterminate colitis [ICD-11: DD72]
P53778 MK12_HUMAN Psoriasis [ICD-11: EA90]
P53779 MK10_HUMAN CNS birth injury [ICD-11: KA40]
P78527 PRKDC_HUMAN Rectum cancer [ICD-11: 2B92]
P78527 PRKDC_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
P78527 PRKDC_HUMAN Prostate cancer [ICD-11: 2C82]
P78527 PRKDC_HUMAN Rectum cancer [ICD-11: 2B92]
P78527 PRKDC_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
P78527 PRKDC_HUMAN Prostate cancer [ICD-11: 2C82]
Q14680 MELK_HUMAN Acute myeloid leukaemia [ICD-11: 2A60]
Q14680 MELK_HUMAN Breast cancer [ICD-11: 2C60-2C6Y]
Q14680 MELK_HUMAN Mature B-cell leukaemia [ICD-11: 2A82]
Q14680 MELK_HUMAN Mature B-cell lymphoma [ICD-11: 2A85]
Q14680 MELK_HUMAN Myelodysplastic syndrome [ICD-11: 2A37]
Q14680 MELK_HUMAN Myeloproliferative neoplasm [ICD-11: 2A20]
Q14680 MELK_HUMAN Acute myeloid leukaemia [ICD-11: 2A60]
Q14680 MELK_HUMAN Breast cancer [ICD-11: 2C60-2C6Y]
Q14680 MELK_HUMAN Mature B-cell leukaemia [ICD-11: 2A82]
Q14680 MELK_HUMAN Mature B-cell lymphoma [ICD-11: 2A85]
Q14680 MELK_HUMAN Myelodysplastic syndrome [ICD-11: 2A37]
Q14680 MELK_HUMAN Myeloproliferative neoplasm [ICD-11: 2A20]
Q15139 KPCD1_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
Q15139 KPCD1_HUMAN Urinary system disease [ICD-11: GC2Z]
Q15418 KS6A1_HUMAN Mature B-cell leukaemia [ICD-11: 2A82]
Q15746 MYLK_HUMAN Duodenal ulcer [ICD-11: DA63]
Q15759 MK11_HUMAN Alzheimer disease [ICD-11: 8A20]
Q15759 MK11_HUMAN Rheumatoid arthritis [ICD-11: FA20]
Q15759 MK11_HUMAN Psoriasis [ICD-11: EA90]
Q8IW41 MAPK5_HUMAN Rheumatoid arthritis [ICD-11: FA20]
Q96SB4 SRPK1_HUMAN Retinopathy [ICD-11: 9B71]
Q9BUB5 MKNK1_HUMAN Breast cancer [ICD-11: 2C60-2C6Y]
Q9BUB5 MKNK1_HUMAN Colorectal cancer [ICD-11: 2B91]
Q9BUB5 MKNK1_HUMAN Liver cancer [ICD-11: 2C12]
Q9BUB5 MKNK1_HUMAN Lymphoma [ICD-11: 2A80-2A86]
Q9BUB5 MKNK1_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
Q9HBH9 MKNK2_HUMAN Breast cancer [ICD-11: 2C60-2C6Y]
Q9HBH9 MKNK2_HUMAN Colorectal cancer [ICD-11: 2B91]
Q9HBH9 MKNK2_HUMAN Liver cancer [ICD-11: 2C12]
Q9HBH9 MKNK2_HUMAN Lymphoma [ICD-11: 2A80-2A86]
Q9HBH9 MKNK2_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
Q9P1W9 PIM2_HUMAN Multiple myeloma [ICD-11: 2A83]
Q9P1W9 PIM2_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
Q9P1W9 PIM2_HUMAN Postoperative inflammation [ICD-11: 1A00-CA43]
Q9UQB9 AURKC_HUMAN Malignant haematopoietic neoplasm [ICD-11: 2B33]
Q9UQB9 AURKC_HUMAN Prostate cancer [ICD-11: 2C82]
Q9UQB9 AURKC_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
O00444 PLK4_HUMAN Breast cancer [ICD-11: 2C60-2C6Y]